BACKGROUND
Factor XIII is of physiological importance for hemostasis, especially in pa
tients undergoing surgery. it catalyzes the enzymatic cross-linking of fibr
in monomers into stable polymers and protects polymers from plasmatic and n
onspecific degradation. Postoperative hemorrhage in patients with congenita
l and acquired Factor XIII deficiencies has been described in various surgi
cal fields. However, there are no data about the incidence and clinical rel
evance of decreased Factor XIII after neurosurgical procedures. The objecti
ve of our study was to investigate the association between Factor XIII defi
ciency and postoperative hemorrhage after intracranial surgery.
METHODS
A total of 1264 patients who underwent intracranial operations were reviewe
d retrospectively Standard coagulation parameters were monitored during the
perioperative course in all patients. Factor XIII testing was performed po
stoperatively in 34 patients in whom coagulopathies were suspected despite
normal platelets, fibrinogen, prothrombin, and partial thromboplastin time.
Data were analyzed to evaluate the association of Factor XIII deficiency a
nd major postoperative hemorrhage.
RESULTS
In this series of 1264 patients, a total of 20 patients (1.6%) suffered fro
m a major postoperative hemorrhage. Of the 34 patients with suspected coagu
lopathies and postoperative Factor XIII testing, II had a major postoperati
ve hemorrhage. Normal levels of Factor XIII, defined as more than 60%, were
found in 26 of the 34 patients. Factor XIII deficiency, defined as less th
an 60%, was found in eight patients. AII patients with Factor XIII deficien
cy (n = 8) had a major postoperative hemorrhage. Of the remaining 26 patien
ts with normal Factor XIII levels only three had a postoperative hemorrhage
(p < 0.00001, Fisher's exact test).
CONCLUSIONS Decreased Factor XIII activity may be associated with an increa
sed risk of postoperative hemorrhage after intracranial surgery. (C) 2000 b
y Elsevier Science Inc.